MedPath

Efficacy and Safety of Jiannao Tongluo Granules in Motor Dysfunction After Cerebral Infarction: a Randomized, Double-Blind, Placebo-Controlled Clinical Trial

Phase 1
Recruiting
Conditions
stroke
Registration Number
ITMCTR2100004804
Lead Sponsor
Hubei Provincial Hospital of Integrated Chinese and Western Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

1. It meets the diagnostic criteria of cerebral infarction and is confirmed by head CT or MRI;
2. Comply with the standard of stroke-wind, phlegm and blood stasis syndrome in traditional Chinese medicine;
3. In the recovery period (the course of illness is 2 weeks to 6 months);
4. Aged 40 to 75 years;
5. For the first time, the vital signs are stable, the consciousness is clear, and they can cooperate with the examination and treatment;
6. There is obvious motor dysfunction, Fugl-Meyer score <=84 points;
7. Volunteer to participate in this study and sign an informed consent form.

Exclusion Criteria

1. Patients with severe cardiovascular, cerebrovascular, liver, kidney, malignant tumors, hematological diseases, and mental illnesses;
2. Transient organic psychosis and other mental illnesses (such as depression, schizophrenia), or other mental disorders that meet the DSM-IV-R standards;
3. Those who are allergic to test drug ingredients, or have a history of alcohol or drug abuse;
4. Women who are pregnant or breastfeeding, or have a pregnancy plan within the past 6 months, or who cannot use effective contraceptive measures (sterilization, long-term use of contraceptives/drugs, condoms, or removal of the vas deferens from their partners, etc.);
5. Participating in other clinical trials or participating in other drug clinical trials within 3 months;
6. The investigator judges the patients who are not suitable to participate in this trial.

Study & Design

Study Type
Interventional study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Fugl-Meyer upper limb rating scale;
Secondary Outcome Measures
NameTimeMethod
TCM symptom score;Modified Rankin Scale;Motor Evoked Potential;National Institute of Health Stroke Scale;Modified Barthel Index;
© Copyright 2025. All Rights Reserved by MedPath